Persevere Therapeutics Launches With Cancer Drug Program and Seed Funding
CHESTERBROOK, PA — Persevere Therapeutics, Inc., a clinical-stage oncology biotechnology company, announced its launch following a period of stealth operations and the initial close of a seed financing round.
Persevere Therapeutics Launches With Cancer Drug Program and Seed Funding Read More